Cargando…
Effective inhibition of MERS-CoV infection by resveratrol
BACKGROUND: Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging viral pathogen that causes severe morbidity and mortality. Up to date, there is no approved or licensed vaccine or antiviral medicines can be used to treat MERS-CoV-infected patients. Here, we analyzed the antiviral a...
Autores principales: | Lin, Shih-Chao, Ho, Chi-Tang, Chuo, Wen-Ho, Li, Shiming, Wang, Tony T., Lin, Chi-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307780/ https://www.ncbi.nlm.nih.gov/pubmed/28193191 http://dx.doi.org/10.1186/s12879-017-2253-8 |
Ejemplares similares
-
Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023) -
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017) -
MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016) -
Atypical presentations of MERS-CoV infection in immunocompromised hosts
por: Kim, Si-Ho, et al.
Publicado: (2017) -
Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)